- Home
- LPTX vs ABTS Comparison
LPTX vs ABTS Comparison
Compare LPTX & ABTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPTX
- ABTS
- Stock Information
- Founded
- LPTX 2011
- ABTS 2010
- Country
- LPTX United States
- ABTS Hong Kong
- Employees
- LPTX N/A
- ABTS N/A
- Industry
- LPTX Biotechnology: Biological Products (No Diagnostic Substances)
- ABTS Computer Software: Programming Data Processing
- Sector
- LPTX Health Care
- ABTS Technology
- Exchange
- LPTX Nasdaq
- ABTS Nasdaq
- Market Cap
- LPTX 11.1M
- ABTS 8.9M
- IPO Year
- LPTX N/A
- ABTS N/A
- Fundamental
- Price
- LPTX $0.29
- ABTS $3.47
- Analyst Decision
- LPTX Hold
- ABTS
- Analyst Count
- LPTX 1
- ABTS 0
- Target Price
- LPTX N/A
- ABTS N/A
- AVG Volume (30 Days)
- LPTX 2.0M
- ABTS 8.8K
- Earning Date
- LPTX 08-14-2025
- ABTS 08-13-2025
- Dividend Yield
- LPTX N/A
- ABTS N/A
- EPS Growth
- LPTX N/A
- ABTS N/A
- EPS
- LPTX N/A
- ABTS N/A
- Revenue
- LPTX N/A
- ABTS $7,037,156.00
- Revenue This Year
- LPTX N/A
- ABTS N/A
- Revenue Next Year
- LPTX N/A
- ABTS N/A
- P/E Ratio
- LPTX N/A
- ABTS N/A
- Revenue Growth
- LPTX N/A
- ABTS 31.69
- 52 Week Low
- LPTX $0.22
- ABTS $1.35
- 52 Week High
- LPTX $4.79
- ABTS $14.10
- Technical
- Relative Strength Index (RSI)
- LPTX 46.11
- ABTS 37.40
- Support Level
- LPTX $0.28
- ABTS $3.40
- Resistance Level
- LPTX $0.31
- ABTS $4.24
- Average True Range (ATR)
- LPTX 0.04
- ABTS 0.24
- MACD
- LPTX 0.00
- ABTS -0.04
- Stochastic Oscillator
- LPTX 39.39
- ABTS 7.69
About LPTX Leap Therapeutics Inc.
Leap Therapeutics Inc is a biopharmaceutical company developing novel biomarker-targeted antibody therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways, targeting cancer-specific cell surface molecules, and harnessing the immune system to attack cancer cells. The company's key clinical-stage drug candidate is sirexatamab (DKN-01), which targets Dickkopf-related protein 1 (DKK1) and is being studied in a clinical trial in patients with colorectal cancer. In addition, it also has a preclinical program to develop a proprietary monoclonal antibody, called FL-501 which works by inhibiting the GDF-15 protein.
About ABTS Abits Group Inc
Abits Group Inc is a digital data center operator with bitcoin self-mining operations. The group has its subsidiaries in USA, China, Canada and Hong Kong.